Top Wall Street Forecasters Revamp Inventiva Expectations Ahead Of H1 Earnings

Benzinga
Sep 29

Inventiva S.A. (NASDAQ: IVA) will release earnings results for the first half of the year, after the closing bell on Monday, Sept. 29.

Analysts expect the Daix, France-based company to report H1 loss at 41 cents per share. Inventiva projects quarterly revenue of $5.31 million, according to data from Benzinga Pro.

Inventiva is scheduled to host Analyst and Investor Event on Oct. 8.

Shares of Inventiva rose 0.7% to close at $6.05 on Friday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

  • HC Wainwright & Co. analyst Ananda Ghosh assumed coverage on the stock with a Buy rating and a price target of $20 on Sept. 3, 2025. This analyst has an accuracy rate of 61%.
  • Guggenheim analyst Etzer Darout maintained a Buy rating and boosted the price target from $9 to $13 on Sept. 2, 2025. This analyst has an accuracy rate of 54%.
  • Piper Sandler analyst Yasmeen Rahimi initiated coverage on the stock with an Overweight rating and a price target of $26 on Aug. 27, 2025. This analyst has an accuracy rate of 66%.
  • Stifel analyst Annabel Samimy maintained a Buy rating and cut the price target from $20 to $17 on Nov. 22, 2024. This analyst has an accuracy rate of 66%.
  • UBS analyst Eliana Merle initiated coverage on the stock with a Neutral rating and a price target of $3 on Nov. 12, 2024. This analyst has an accuracy rate of 53%

Considering buying IVA stock? Here’s what analysts think:

Read This Next:

  • How To Earn $500 A Month From Lamb Weston Stock Ahead Of Q1 Earnings

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10